Angermayer Christian
CIK 0001845872 Name as filed on the most recent filing
Filed as Angermayer Christian (18)
28 transaction lines · from 18 filings · filed 2021-06-24 to 2026-08-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Enhanced Group Inc. 2 filings
- ISSUER Atai Life Sciences N.V. 13 filings
- ISSUER Bionomics Ltd/ADR 1 filings
- ISSUER Sensei Biotherapeutics, Inc. 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
1 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-17 |
Enhanced Group Inc. ENHA |
P, Open-market purchase | 200,000 acquired | 1.65 | 330,420.00 | Form 4, filing 0001193125-26-354788 | |
| 2026-08-14 |
Enhanced Group Inc. ENHA |
P, Open-market purchase | 150,000 acquired | 1.97 | 295,620.00 | Form 4, filing 0001193125-26-353161 | |
| 2025-08-14 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 8,675,799 acquired | 2.19 | 18,999,999.81 | Form 4, filing 0000950170-25-109858 | |
| 2025-03-24 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 1,800,000 acquired | 1.40 | 2,520,000.00 | Form 4, filing 0000950170-25-043942 | |
| 2025-02-14 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 10,835,718 acquired | 2.10 | 22,755,007.80 | Form 4, filing 0000950170-25-023436 | |
| 2024-10-04 |
Bionomics Ltd/ADR BNOX |
S, Open-market sale | 557 disposed | 0.28 | 155.96 | Form 4, filing 0000950170-24-113344 | |
| 2024-10-03 |
Bionomics Ltd/ADR BNOX |
S, Open-market sale | 180,707 disposed | 0.29 | 52,405.03 | Form 4, filing 0000950170-24-113344 | |
| 2024-10-02 |
Bionomics Ltd/ADR BNOX |
S, Open-market sale | 90,806 disposed | 0.33 | 29,965.98 | Form 4, filing 0000950170-24-113344 | |
| 2023-06-01 |
Sensei Biotherapeutics, Inc. SNSE |
S, Open-market sale | 2,485,923 disposed | 1.58 | 3,927,758.34 | Form 4, filing 0000921895-23-001420 | |
| 2023-06-01 |
Sensei Biotherapeutics, Inc. SNSE |
S, Open-market sale | 955,738 disposed | 1.58 | 1,510,066.04 | Form 4, filing 0000921895-23-001420 | |
| 2023-03-29 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 1,214,297 acquired | 1.32 | 1,600,443.45 | Form 4, filing 0000899243-23-009973 | |
| 2023-02-23 |
Sensei Biotherapeutics, Inc. SNSE |
P, Open-market purchase | 1,100 acquired | 1.62 | 1,776.50 | Form 4, filing 0000921895-23-000615 | |
| 2023-02-23 |
Sensei Biotherapeutics, Inc. SNSE |
P, Open-market purchase | 1,100 acquired | 1.60 | 1,762.53 | Form 4, filing 0000921895-23-000615 | |
| 2022-04-29 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 21,900 acquired | 4.47 | 97,801.02 | Form 4, filing 0000899243-22-016117 | |
| 2022-04-28 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 34,700 acquired | 4.46 | 154,689.13 | Form 4, filing 0000899243-22-016117 | |
| 2022-04-27 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 19,803 acquired | 4.64 | 91,939.39 | Form 4, filing 0000899243-22-015852 | |
| 2022-04-26 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 46,207 acquired | 4.69 | 216,627.66 | Form 4, filing 0000899243-22-015852 | |
| 2022-04-25 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 8,961 acquired | 4.78 | 42,842.54 | Form 4, filing 0000899243-22-015653 | |
| 2022-04-22 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 52,820 acquired | 4.83 | 254,962.14 | Form 4, filing 0000899243-22-015653 | |
| 2022-04-21 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 68,688 acquired | 4.95 | 340,039.94 | Form 4, filing 0000899243-22-016301 | |
| 2022-04-20 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 67,703 acquired | 5.09 | 344,513.49 | Form 4, filing 0000899243-22-016301 | |
| 2022-04-19 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 65,315 acquired | 5.12 | 334,739.38 | Form 4, filing 0000899243-22-015168 | |
| 2022-04-18 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 54,322 acquired | 5.11 | 277,656.04 | Form 4, filing 0000899243-22-015168 | |
| 2022-04-14 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 4,967 acquired | 5.19 | 25,778.73 | Form 4, filing 0000899243-22-014963 | |
| 2022-04-12 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 55,197 acquired | 4.88 | 269,560.07 | Form 4, filing 0000899243-22-014797 | |
| 2022-04-11 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 53,926 acquired | 4.83 | 260,554.25 | Form 4, filing 0000899243-22-014575 | |
| 2022-04-08 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 57,689 acquired | 4.81 | 277,639.85 | Form 4, filing 0000899243-22-014575 | |
| 2021-06-22 |
Atai Life Sciences N.V. ATAI |
P, Open-market purchase | 700,000 acquired | 15.00 | 10,500,000.00 | Form 4, filing 0000899243-21-025736 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 0
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Angermayer Christian, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001845872
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6